Category: COVID

Summary of Key Points: New Optional Event-Level COVID-19 Vaccination Forms in NHSN (replacing the Excel Data Tracking Worksheets)

Posted on

The NHSN Vaccination Team hosted two office hours webinars for the Event-Level COVID-19 Vaccination Forms on Tuesday, April 12th and Tuesday, April 19th. During these webinars, CDC provided long-term care facilities with an overview of how to use this feature to manage person-level vaccination data directly in the application for the COVID-19 Vaccination Modules and discussed frequently asked questions in detail.

The slides used during the webinars are linked under the “Educational Resources” section of this message, and webinar recordings will be posted on the NHSN website at a later date.

Summary of Key Points:

  • The Event-Level COVID-19 Vaccination Forms are available in the NHSN application for long-term care facilities (other modules coming soon) to manage person-level vaccination data and simplify summarizing data for weekly COVID-19 Vaccination Modules.
  • There are three ways to report data: directly into the COVID-19 Vaccination Modules, via .CSV upload, or by selecting the ‘View reporting summary and submit’ button of the Event-Level COVID-19 Vaccination Forms.
  • SAMS Level 3 access is required to complete reporting using the Event-Level COVID-19 vaccination forms. If your facility does not have a Level 3 user, please contact the SAMS Help Desk between the hours of 8:00 AM and 8:00 PM EST Monday through Friday (excepting U.S. Federal holidays) at the following: Toll Free: 877-681-2901; E-mail: samshelp@cdc.gov. You can also find additional information in the SAMS User FAQs published on the SAMS Homepage at https://sams.cdc.gov.
  • Data are entered line by line in the optional Event-Level COVID-19 Vaccination Forms, similar to the Excel Data Tracking Worksheet.
  • You can complete a one-time upload of any current data in the Excel Data Tracking Worksheet to the NHSN Event-Level COVID-19 Vaccination Forms. Once your data are transferred to the NHSN application, do not continue to use/re-upload the Excel Data Tracking Worksheet because the two tools do not function the same way.
  • You can export a .CSV file and upload data via .CSV .CSV files templates and examples for healthcare personnel and residents of long-term care facilities are available on the NHSN website: https://www.cdc.gov/nhsn/pdfs/ltc/covidvax/c19-event-layout-508.pdf.
  • There is no need to enter a new line for an individual each week or when their status changes; instead, Event-Level COVID-19 Vaccination Forms capture changes in individuals’ vaccination status over time.

The one exception is for extended leave. If a healthcare worker goes on leave for longer than 2 weeks (14 days) and returns to work after more than 2 weeks, or if a resident is discharged or leaves the facility for any reason for longer than 1 week (7 days) and returns or is re-admitted after more than 1 week:

– You should enter a discharge/end date on the day they were discharged or left.

– When they return or are re-admitted, you should duplicate their row (using the + button next to their row) and enter a new admission date on their new row.

  • These forms allow users to record religious exemption as a reason for declining COVID-19 vaccination.
  • 2nd booster dose fields will be added to the forms.

Coming Soon – May 2022 Release:

  • The Event-Level COVID-19 Vaccination Forms will include new columns to record second and third booster doses.
  • The weekly summary form will include a question on “number of individuals who are up to date on COVID-19 vaccines.” This field will be auto-calculated for those using and submitting data with the Event-Level COVID-19 Vaccination Forms.
  • The weekly resident summary form will include questions on number of residents who received only one booster dose, and number of residents who received two or more booster doses. These fields will be auto-calculated for those using and submitting data with the Event-Level COVID-19 Vaccination Forms.
  • Rows will no longer appear green after submission for individuals with a discharge date earlier than 3/28/2022.

Note: NHSN encourages facilities to enter the same IDs for residents and healthcare personnel as those used for reporting the POC Tool and the RIFC Event-Level Form when applicable.

Educational Resources:

For specific information about CMS reporting requirements for long-term care facilities, please contact CMS at: DNH_TriageTeam@cms.hhs.gov.

Reporting of Positive COVID-19 Cases – Changes Effective Monday, April 18th

Posted on

Effective April 18, 2022, the existing Electronic COVID-19 Case Reporting System (ECD-1) will be disabled. This system will be replaced by the Missouri Disease Reporting Online Portal (MODROP). MODROP can be accessed directly from https://modrop.health.mo.gov/ or by using the existing ECD-1 link at https://health.mo.gov/living/healthcondiseases/communicable/novel-coronavirus/case-reporting.php and selecting the MODROP button.

NOTE: The recommended browser for use of MODROP is Google Chrome. Other browsers may cause issues with MODROP.

Facilities will need to register for a MODROP account the first time they use the new portal. MODROP allows reporting of only COVID-19 cases. Reports of other reportable conditions may be faxed to 573-751-6417.

Facilities performing their own COVID-19 testing (antigen testing) must report positive results through one of the following portals:

  • MODROP
  • In bulk via HL7 or CSV file using the DHSS- Electronic Lab Reporting process
  • National Healthcare Safety Network (NHSN) or the Association of Public Health Laboratories (APHL) Informatics Messaging Services (AIMS) Platform.

Facilities using an external laboratory (PCR testing) must enter positive case information into MODROP.

We are excited for this change and elimination of duplicate reporting of positive cases! If you have any questions or encounter any issues utilizing MODROP or for questions about HL7 or CSV reporting, please reach out to the EpiTrax Help Desk via e-mail at epitrax@health.mo.gov. The EpiTrax Help Desk e-mail account is monitored from 8AM-5PM CST Monday-Friday.

Please see the FAQ and thank you for your efforts to provide complete and accurate COVID-19 data to public health.

Office Hours and Frequently Asked Questions Webinar for the Optional Event-Level

Posted on

The NHSN Vaccination Team is providing two webinars on Tuesday, April 12th and Tuesday, April 19th at 2:00 PM Eastern Time to provide additional training on the Event-Level COVID-19 Vaccination Forms in the COVID-19 Vaccination Modules and to answer frequently asked questions. These worksheets are available in the NHSN application for long-term care facilities (other modules coming soon!) to manage person-level vaccination data and simplify data for weekly COVID-19 Vaccination Modules.

During this session, the team will review key points about the forms and provide answers to frequently asked questions raised during the training webinars held in March 2022. Users attending the training can also ask questions in in the Q&A box.

Registration information for both webinars is listed below. The content for both webinars will be the same, but individuals are welcome to register for and join both for additional reinforcement if they choose.

When: Tuesday, April 12, 2022 at 02:00 PM Eastern Time (US and Canada)
Topic: Event-Level COVID-19 Vaccination Forms: Office Hours and FAQs

Register in advance for this webinar: https://cdc.zoomgov.com/webinar/register/WN_CQN5faRJTRictvPA512RmA
After registering, you will receive a confirmation email containing information about joining the webinar.

When: Tuesday, April 19, 2022 at 02:00 PM Eastern Time (US and Canada)
Topic: Event-Level COVID-19 Vaccination Forms: Office Hours and FAQs

Register in advance for this webinar: https://cdc.zoomgov.com/webinar/register/WN_asYca_YuTj2gzJbMiFM7ow
After registering, you will receive a confirmation email containing information about joining the webinar.

For specific questions about registration for this webinar, please e-mail NHSN@cdc.gov and place in the subject line: Event-Level COVID-19 Vaccination Form Office Hours.

Health Update: Reporting COVID-19 Cases and SARS-CoV-2 Test Results

Posted on

April 6, 2022: Update: Reporting COVID-19 Cases and SARS-CoV-2 Test Results

The Missouri Department of Health and Senior Services (DHSS) is issuing this Health Update to provide reporting laboratories and healthcare providers information regarding the changes in the reporting requirements for COVID-19 and SARS-CoV-2 test results in Missouri.

During the early stages of the pandemic response there were several changes to the reporting rules that were established through waivers during the State of Emergency issued by Governor Parson. The changes included the requirement that both negative and positive test results for COVID-19 were to be reported to DHSS within twenty-four hours. Additionally, reporters were required to only report directly to DHSS rather than having the option to report to either the Local Public Health Agency (LPHA) or DHSS. After the State of Emergency was lifted by Governor Parson, DHSS filed an emergency amendment to allow these requirements to continue. However, on April 1, 2022, DHSS terminated this emergency amendment and as a result, these requirements no longer exist. Please consider the following guidance regarding the reporting of COVID-19 and laboratory tests results for SARS-CoV-2.

Coronavirus Disease 2019 (COVID-19) remains an immediately reportable condition in Missouri. All positive laboratory results are required to continue to be reported to DHSS or the LPHA in accordance with rules established in 19 CSR 20.20.020. Healthcare providers, laboratories, and other mandated reporters should continue to report all COVID-19 positive test results including results from all Nucleic Acid Amplification Tests such as RT-PCR tests, and all rapid and antigen tests results for SARS-CoV-2. The reporting of positive home use tests is optional. However, DHSS will no longer require, or accept, negative laboratory results for SARS-CoV-2. In addition, DHSS is no longer requesting the routine reporting of positive or negative antibody tests results for SARS-CoV-2.

DHSS greatly appreciates the continued collaboration of our partners in healthcare and clinical laboratories. For questions regarding this Health Update and the reporting of COVID-19 in Missouri, please contact the DHSS Bureau of Communicable Disease Control and Prevention at 573-751-6113 or 800-392-0272 (24/7), or contact your local public health agency.

CMS Memo: QSO-22-15-NH & NLTC & LSC

Posted on

Update to COVID-19 Emergency Declaration Blanket Waivers for Specific Providers

  • CMS continues to review the need for existing emergency blanket waivers issued in response to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE).
  • Over the course of the COVID-19 PHE, skilled nursing facilities/nursing facilities (SNFs/NFs), inpatient hospices, intermediate care facilities for individuals with intellectual disabilities (ICF/IIDs), and end-stage renal disease (ESRD) facilities have developed policies or other practices that we believe mitigates the need for certain waivers.
  • Applicable waivers will remain in effect for hospitals and critical access hospitals (CAH).
  • CMS will end the specified waivers in two groups:
    • 60 days from issuance of this memorandum
    • 30 days from issuance of this memorandum

Please see the full memo at https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/update-covid-19-emergency-declaration-blanket-waivers-specific-providers.

Report Release Webinar: The National Imperative to Improve Nursing Home Quality

Posted on

April 6, 2022: The National Imperative to Improve Nursing Home Quality: Report Release Webinar

Join the National Academies of Sciences, Engineering, and Medicine’s Committee on The Quality of Care in Nursing Homes as it discusses the soon to be released report, The National Imperative to Improve Nursing Home Quality: Honoring Our Commitment to Residents, Families and Staff.

This new report examines how our nation delivers, finances, regulates, and measures the quality of nursing home care with particular emphasis on challenges that have arisen in light of the COVID-19 pandemic.

A public report release webinar will be held on Wednesday, April 6, 2022 from 10:00 AM to 11:00 AM (Central Time) during which members of the committee will provide an overview of key findings, conclusions, and recommendations, followed by a moderated question and answer period.

HQIN COVID-19 Vaccine Office Hours

Posted on

Have You Had Your Weekly Dose?

The Health Quality Innovation Network’s Weekly Dose Office Hours webinar series provides current updates on COVID-19 guidance and vaccine information. As a Medicare Quality Innovation Network – Quality Improvement Organization (QIN-QIO), HQIN is dedicated to helping you increase your vaccination rates.

This forum for vaccine and booster questions features interactive, peer-to-peer collaboration following a brief presentation. Each session includes best practices and innovative idea sharing as well as tips for improving resident and staff safety. Weekly Dose Office Hours are held Wednesdays at 1:00 p.m. CT/2:00 pm. ET. Register for the next Office Hours, as well as upcoming sessions, at this link: https://tinyurl.com/575d66tn.

For a 30-second overview of the Office Hours, watch this brief video: https://tinyurl.com/2p83yhjy.

MANHA’s 2022 Annual Convention

Posted on

June 5-8, 2022: Mandatory PPE – People Pride Endurance
Location: Camden on the Lake, Lake Ozark

Missouri Association of Nursing Home Administrators is pleased to invite you to attend our 2022 Annual Convention. This conference is a focus on the Administrators and staff after an unprecedented 2 years. The goal of this conference is to provide meaningful, forward thinking, and real-time education to pave the path forward while acknowledging the past and working through hard topics, together.

CMS Memo: QSO-20-38-NH: Interim Final Rule (IFC), CMS-3401-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency related to Long-Term Care (LTC) Facility Testing Requirements REVISED 03/10/2022

Posted on
  • CMS is committed to taking critical steps to ensure America’s healthcare facilities continue to respond effectively to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE).
  • On August 25, 2020, CMS published an interim final rule with comment period (IFC). This rule establishes Long-Term Care (LTC) Facility Testing Requirements for Staff and Residents. Specifically, facilities are required to test residents and staff, including individuals providing services under arrangement and volunteers, for COVID-19 based on parameters set forth by the HHS Secretary. This memorandum provides guidance for facilities to meet the new requirements.
  • Replaced the term “vaccinated” with “Up-to-date with all recommended COVID-19 vaccine doses” and deleted the term “unvaccinated.”
  • Updated the recommendations for testing individuals within 90 days after recovering from COVID-19.

Please see the full memo at https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/interim-final-rule-ifc-cms-3401-ifc-additional-policy-and-regulatory-revisions-response-covid-19-0.

CMS Memo: QSO-20-39-NH: Nursing Home Visitation – COVID-19 REVISED 03/10/2022

Posted on
  • CMS is committed to continuing to take critical steps to ensure America’s healthcare facilities are prepared to respond to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE).
  • Visitation Guidance: CMS is issuing new guidance for visitation in nursing homes during the COVID-19 PHE, including the impact of COVID-19 vaccination.
  • Visitation is allowed for all residents at all times.
  • Replaced the term “vaccinated” with “up-to-date with all recommended COVID-19 vaccine doses” and deleted “unvaccinated.”
  • Updated visitor screening and quarantine criteria.

Please see the full memo at https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/nursing-home-visitation-covid-19-revised.

COVID-19 Reporting Changes

Posted on

Effective 2/26/2022, facilities (RCF, ALF, SNF, ICF, and ICF-IID) no longer need to report the aggregate number of residents and staff tested during outbreak testing to the DHSS redcap portal. Below is a chart which outlines current reporting requirements.

 

Reporting Process/Form

System

Purpose/Description

Required?
For Whom?

Time Frame

1

Electronic COVID-19 Case Reporting

REDCap: DHSS

Reporting form for all positive case results, including staff and residents. This includes POC and PCR testing.**

Yes, for all SNF, ICF, RCF, ALF, ICF-IID and Adult Day Care

Within 24 hours of positive result

2

NHSN LTCF COVID-19 Module

Web Portal: Managed by NHSN

NHSN-required fields solely for certified nursing homes (SNF/NFs).

Yes, for all certified SNF/NF. Voluntary for any state licensed only facility (RCF/ALF/Adult Day Care) or ICF-IID.

Weekly, with a preference for submission on the same day each week

3

NHSN Point of Care Laboratory Reporting Tool

Web Portal: NHSN

POC test reporting that includes both positive and negative POC test results (even if potentially a false positive).

Yes, for any facility not reporting to DHSS in Row 4

Within 24 hours of result of POC test

4

Electronic COVID-19 Laboratory Reporting

Secure File Transfer/CSV file: DHSS

POC test reporting that includes both positive and negative POC test results (even if potentially a false positive).

Yes, for any facility not reporting to NHSN in Row 3

Within 24 hours of result of POC test

 

**Effective 2/25/2022, the Electronic COVID-19 Case Reporting System now requires entry of laboratory (testing) information when Positive Test for COVID-19 is selected as the Reason for Reporting. This change will allow for the data to more easily be ingested into Epitrax and readily available to Local Public Health Agencies- reducing follow-up contacts and calls to facilities to obtain the information.

 

#VoicesOfLongCovid Campaign

Posted on

DHSS is collaborating with Resolve to Save Lives, an initiative of the global health organization Vital Strategies, to launch their “Voices of Long COVID” campaign throughout Missouri to increase public awareness of the impact of and unknowns associated with Long COVID. Our end goal is to encourage vaccine uptake, particularly among people ages 18-29, so fewer Missourians struggle with the devastating effects of Long COVID.

The “Voices of Long COVID” campaign features testimonials from a diverse group of people ages 18-29 who are suffering from long-term complications of COVID-19 infection. The initiative follows Resolve to Save Lives’ recent national survey, which found that nearly a third of American adults are unaware of Long COVID, and that long-hauler stories can motivate 40% of unvaccinated people to consider getting a COVID-19 vaccine.

“The brave young adults featured in the campaign are sharing their reality in order to help others avoid the harms of COVID infection,” said Dr. Tom Frieden, President and CEO of Resolve to Save Lives (and former CDC director). “Thousands of Americans struggle with Long COVID every day. Their stories are important reminders that vaccination is our best tool to prevent this potentially life-altering condition.”

The campaign shows the real-life stories of three COVID long-haulers who have been battling debilitating health problems over the past year believed to be caused by their original COVID-19 infection:

  • Katelyn Van Dyke, a 20-year-old Mizzou student who got COVID-19 in November 2020 and now has trouble breathing when walking and severe memory loss.
  • Rob Smith, a 22-year-old who used to run five miles a day and now struggles to climb stairs, maintain a healthy social life and manage the uncertainty of his COVID-19 recovery due to ongoing fatigue and brain fog. He shares his story in Spanish and English.
  • Isaiah Smith, a 26-year-old U.S. Air Force veteran, part-time student and essential worker who became infected with COVID-19 in October 2020 and now experiences extreme nausea, chest pain, shortness of breath, dizziness upon standing, heart palpitations and challenges with comprehension.

The patients spotlighted in the campaign want to warn others about the risks of being unvaccinated.

“Long COVID is real, and the struggle goes beyond what you can see,” Van Dyke said. “We don’t know enough about this condition yet, and there’s a good chance all of us know at least one person who is suffering from this. The best way to prevent COVID-19 and long COVID is to get vaccinated.”

“I’ve learned over the course of the past year that you should always value your personal health-this is especially needed among people who are refusing to get vaccinated,” said Rob Smith. “I’ve been trying to educate people about the long-term effects of COVID and the safety of the vaccine. The trade-off between COVID and the vaccine is not even close.”

Isaiah Smith is sharing his long COVID story “because I don’t want anyone else to experience what I’m going through.” He noted that some of his friends are vaccine-hesitant. “I tell them to talk to their doctor about getting the vaccine. They should avoid getting COVID at all costs because at the end of the day, they’re rolling the dice on what happens afterwards-they have no idea what’s going to happen.”

Missouri’s Long COVID webpage is at MOStopsCovid.com/LongHaul. If you would like to share educational materials, they can be found in both English and Spanish at this link.

Included are:

  • Web banners in various sizes
  • Radio ads in both 15- and 30-second spots
  • Videos
    • 15-second videos formatted for YouTube and Tremor
    • 15- and 30-second stories formatted for Facebook, Instagram and Snapchat

State Antigen Testing Supply Portal Re-Opening Soon –

Posted on

Please Read Information Below Carefully!

The Missouri Department of Health and Senior Services (DHSS) is pleased to announce that effective Thursday, February 10, 2022 at 8:00 a.m., we are reopening our antigen testing program! As you are aware, due to a nation-wide shortage of antigen tests and issues with receipt of tests from our distributor, it was necessary for us to suspend that program indefinitely in early January. For awareness, although Friday, February 11, 2022 is a state holiday, we will be accepting requests for tests, but no tests will be shipped on that day.

We have subsequently identified two distributors with adequate supply of ACON Flow Flex rapid antigen tests to allow us to reopen our antigen testing program. Information about ACON Flow Flex can be found here.

The transition to this different rapid antigen test requires the establishment of a new state-wide CLIA (although organizations with their own CLIA can continue to use their own) and thus verification of locations of testing and validation of training of all test administrators. Thus, it is not possible to simply transition existing BinaxNOW users to ordering for ACON Flow Flex – all existing users will need to re-apply to receive ACON Flow Flex, take the required training and provide verification of that training, resubmit a test plan inclusive of the infectious waste disposal plan, and provide the locations of testing in order to be approved to receive tests. Note: For organizations using their own CLIA, please be sure to add ACON Flow Flex to your CLIA waiver by contacting the state CLIA program (see additional information below).

New standing physician’s orders specific to ACON Flow Flex have been established for all tests users previously under a DHSS standing physician’s order. These new orders are available at: https://health.mo.gov/living/healthcondiseases/communicable/novel-coronavirus/testing-resources.php.

The DHSS Rapid Antigen Test Kit Application and Resource web page includes the initial application and a subject index to answer questions we received during the previous distribution of antigen tests. The page also provides information about where to direct specific questions that test users may encounter. If a test user is unsure of where to direct a question, please contact antigentesting@health.mo.gov.

The DHSS Rapid Antigen Test Kit Application and Resource Page for ACON Flow Flex will be open effective 8:00 a.m. on Thursday, February 10, 2022 at: https://health.mo.gov/living/healthcondiseases/communicable/novel-coronavirus/testing-resources.php.

Thank you for your continued work to fight COVID!

 

Adding ACON Flow Flex to Your CLIA Test Menu

The CLIA program has developed an email template that you can copy and paste, fill in the blanks, and email to CLIA@health.mo.gov to update your test menu to include ACON Flow Flex.

Email Subject line: Add COVID-19 Testing to existing CLIA Certificate for [FACILITY NAME]

Lab/Facility Name:  
Existing CLIA Waived Lab #:  
Lab Director Name:  
Which COVID-19/ SARS-CoV-2 Waived Test system added?
Check [X] all that may apply.

[    ] Abbott BinaxNOW COVID-19 Ag Card
[    ] Acon FlowFlex
[    ] Quidel Sofia 2 SARS-CoV-2 Antigen assay
[    ] Becton Dickinson Veritor™ Plus Antigen test kit
[    ] Abbott ID Now
[    ] OTHER Waived test(s) approved by FDA EUA (specify below):

As the Laboratory Director or administrator/owner’s agent of record for the CLIA facility holding a Waived Certificate identified above, I wish to append my facility’s existing CLIA# to include additional testing for COVID-19. I attest that my facility will provide reasonable assurances that:

  • All testing personnel for COVID-19 will be provided adequate and documented training
  • All Manufacturer’s Instructions for Use (IFU) will be strictly adhered to

All tests results (both positive and negative) will be reported to the proper public health entities under federal and state requirements. See MO DHSS link regarding reporting: https://health.mo.gov/living/healthcondiseases/communicable/novel-coronavirus/how-to-report-lab-results.php

Updated CDC Guidance

Posted on

On February 2, 2022, CDC updated the following healthcare infection prevention and control (IPC) guidance documents: Infection Control: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | CDC and Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes | CDC.

Updates were made in these guidance documents to align with prior updates made for healthcare personnel with higher-risk exposures in the Interim Guidance for Managing Healthcare Personnel with SARS-COV-2 Infection or Exposure to SARS-CoV-2, which was released on December 23, 2021.

A review of the updates was given on a recent Clinician Outreach and Communication Activity (COCA) Call, which was recorded and is accessible here: Webinar January 13, 2022 – Updates to CDC’s COVID-19 Quarantine and Isolation Guidelines in Healthcare and Non-healthcare Settings. Additionally, a brief summary of the updates can be found below. Please consult the guidance documents for the full recommendations.

Vaccination status

Use of N-95 respirators

*Please see complete guidance for full personal protective equipment recommendations

  • CDC continues to recommend gown, gloves, eye protection and a NIOSH-approved N95 or equivalent or higher-level respirator when caring for patients known or suspected to be infected with SARS-CoV-2.
  • In counties with substantial to high community transmission, a NIOSH-approved N95 or equivalent or higher-level respirator is also recommended instead of a facemask when caring for patients not known or suspected to have SARS-CoV-2 infection in the following higher-risk situations:
    • All aerosol-generating procedures;
    • Higher-risk surgical procedures;
    • These respirators can also be used by HCP in situations where additional risks for infection are present, such as caring for a patient who is not up to date with all recommended COVID-19 vaccine doses, the patient is not able to wear source control, and the area is poorly ventilated. They may also be used if healthcare-associated SARS-CoV-2 transmission is identified.

 Viral testing

  • CDC continues to emphasize that anyone with even mild symptoms of COVID-19, regardless of vaccination status, should receive a viral test as soon as possible.
  • Asymptomatic patients with close contact with someone with SARS-CoV-2 infection, regardless of vaccination status, should have a series of two viral tests for SARS-CoV-2 infection.
    • Generally, test immediately (but not earlier than 24 hours after the exposure) and, if negative, again 5-7 days after the exposure.
  • Testing is not generally necessary for asymptomatic people who have recovered from SARS-CoV-2 infection in the prior 90 days; however, if tested, an antigen test instead of a nucleic acid amplification test (NAAT) is recommended as some people may remain NAAT positive after they are no longer infectious.

Criteria to end isolation for patients with SARS-CoV-2 infection cared for in a healthcare facility

  • Asymptomatic patients or those with mild to moderate illness and who are not moderately to severely immunocompromised: manage with recommended precautions for 10 days after their symptoms first appeared.
  • Patients with severe to critical illness and who are not moderately to severely immunocompromised: manage with recommended precautions until at least 10 days and up to 20 days have passed since symptoms first appeared.
  • Symptomatic and asymptomatic patients who are moderately to severely immunocompromised: a test-based strategy and (if available) consultation with an infectious disease specialist or other expert is recommended to determine when these patients can be released from isolation.

Quarantine for patients:

  • Empiric use of Transmission-Based Precautions (quarantine) is recommended for patients who have had close contact with someone with SARS-CoV-2 infection if they are not up to date with all recommended COVID-19 vaccine doses. Duration of quarantine is described in the guidance.
  • Quarantine is not generally needed following close contact with someone with SARS-CoV-2 infection for asymptomatic patients who are up to date on all recommended COVID-19 vaccine doses or who have recovered from infection in the prior 90 days. Potential exceptions are described in the guidance.

Visitation

  • Even if they have met community criteria to discontinue isolation or quarantine, visitors should not visit if they have any of the following and have not met the same criteria used to discontinue isolation and quarantine for patients (typically until 10 days after last exposure or onset of symptoms has passed):

1) A positive viral test for SARS-CoV-2,
2) Symptoms of COVID-19, or
3) Close contact with someone with SARS-CoV-2 infection

  • If visitation cannot be postponed the visitor might be subject to additional precautions.

This guidance on infection prevention and control will continue to be refined as additional information becomes available.

New QIPMO Newsletter – February 2022

Posted on

The Quality Improvement Program for Missouri (QIPMO) has published MDS Tips and Clinical Pearls (Volume 9, Issue 2).

In this issue:

  • How Does the Vaccine Work?
  • Regulation Road
  • Hold It! Insulin Administration
  • COVID Isolation Coding
  • ICAR Corner: Hand Hygiene
  • Coagulation and COVID-19
  • Meeting Universal Needs

Please visit QIPMO’s website here for this and other previous newsletters.

NHSN – Reporting Cumulative Vaccination Data on Additional and Booster Doses

Posted on

National Healthcare Safety Network Users:

This is a reminder that for weekly COVID-19 vaccination data reporting, you should be reporting cumulative data for Question 5, the number of individuals who have received an additional or booster dose. This means that for each reporting week, you should be reporting the total number of individuals in Question 1 who have ever received an additional or booster dose of COVID-19 vaccine as of that week, since additional/booster doses became available in August 2021. You should not limit reporting to the number of individuals who received new additional/booster doses of COVID-19 vaccine during that reporting week.

To accurately report cumulative COVID-19 vaccination data for a reporting week, you should first report the total number of individuals at the facility for that week (Question 1).

  • For Question 2 (primary vaccination series): Of the individuals reported in question #1, report the number of individuals who have ever received COVID-19 vaccination (at that facility or elsewhere) since it became available in December 2020.
  • For Question 5 (additional/booster doses): Of the individuals reported in question #1, report the number of individuals who have ever received an additional or booster dose (at that facility or elsewhere) since August 2021.

For additional guidance on how to report cumulative data, please see the following Quick Learn demonstration, posted on the NHSN Vaccination website at: Reporting Weekly Cumulative COVID-19 Vaccination Data (cdc.gov).

We appreciate your time and effort reporting COVID-19 vaccination data in NHSN. Please contact NHSN@cdc.gov with “COVID-19 Vaccination” in the subject line with any additional questions or concerns.

FDA Authorized BinaxNOW Expiry Extension

Posted on

The Food and Drug Administration (FDA) has authorized an expiry extension for BinaxNOW tests for three months from the current expiration date listed on the external box. The expiration date to reference is the one on the outside of the box by the hourglass icon. Individual components inside the box will have varying expiration dates, do not pay attention to those dates – only the expiration date on the outside of the box beside the hour glass icon.

Any organizations with tests currently expired are encouraged to check expiration dates as this FDA announcement allows use of expired tests up to three months from current expiration date.

https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2

Below is an attachment from Abbott including the box lot #s that have been extended.
COL-03031 v03 BinaxNOW™ COVID-19 Ag Card Product Expiry Update (002)

Guidance for the Interim Final Rule – Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination

Posted on

https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/guidance-interim-final-rule-medicare-and-medicaid-programs-omnibus-covid-19-health-care-staff-1

The guidance in this memorandum specifically applies to the following states: Alabama, Alaska, Arizona, Arkansas, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, New Hampshire, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Utah, West Virginia and Wyoming.

Please read the memo in its entirety. Some key points in the memo:

Within 30 days after the issuance of the memorandum, if a facility demonstrates:

  • Policies and procedures are developed and implemented for ensuring all facility staff, regardless of clinical responsibility or resident contact are vaccinated for COVID-19, including all required components of the policies and procedures specified below (e.g., related to tracking staff vaccinations, documenting medical and religious exemptions, etc.); and
  • 100% of staff have received at least one dose of COVID-19 vaccine or have a pending request for, or have been granted a qualifying exemption, or are identified as having a temporary delay as recommended by the CDC, the facility is compliant under the rule.

Within 60 days after the issuance of the memorandum if a facility demonstrates:

  • Policies and procedures are developed and implemented for ensuring all facility staff, regardless of clinical responsibility or resident contact are vaccinated for COVID-19, including all required components of the policies and procedures specified below (e.g., related to tracking staff vaccinations, documenting medical and religious exemptions, etc.); and
  • 100% of staff have received the necessary doses to complete the vaccine series (i.e., one dose of a single-dose vaccine or all doses of a multiple vaccine series) or have been granted a qualifying exemption, or are identified as having a temporary delay as recommended by the CDC, the facility is compliant under the rule.

 Within 90 days and thereafter following issuance of the memorandum, facilities failing to maintain compliance with the 100% standard may be subject to enforcement action.

Visitation in Long-Term Care Facilities (RCF, ALF, ICF and SNFs)

Posted on

SLCR has received several questions recently regarding visitation in long-term care facilities. All previous guidance provided by DHSS regarding visitation is no longer in effect. No state waivers are in place regarding regulatory or statutory requirements related to visitation. Section 198.088.6(K), RSMo states, “Each resident admitted to the facility may communicate, associate and meet privately with persons of his choice, unless to do so would infringe upon the rights of other residents.” State regulations also require facilities to follow appropriate infection control procedures. To balance these two requirements, all long-term care facilities (RCF, ALF, ICF and SNF) should follow CDC guidance related to visitors: https://www.cdc.gov/coronavirus/2019-ncov/hcp/long-term-care.html#anchor_1631030962190. The CDC guidance points facilities to CMS’ memo for additional information related to visitation. Certified facilities are required to follow CMS guidelines. Although state licensed only facilities are not required to follow the requirements in QSO 20-39 NH, DHSS highly encourages them to use the memo and FAQs as a standard of practice to ensure safe visitation occurs in their long-term care community.

CMS has developed a Frequently Asked Questions document to address the questions received regarding visitation in Nursing Homes. This additional information is provided to help residents, families and providers ensure that safe visitation can occur. The FAQs can be found on the cms.gov emergencies page here and also in QSO-20-39-NH REVISED.

NHSN Updated COVID-19 Data Tracking Worksheet

Posted on

National Healthcare Safety Network Users:

Recently, some NHSN users were unable to use the COVID-19 vaccination data tracking worksheet for surveillance weeks in 2022. The vaccination data tracking worksheets for the COVID-19 Vaccination Modules have been updated, and facilities can now enter data for 2022 in the worksheets. You can find the updated vaccination data tracking worksheets on the following CDC NHSN webpages under the “Data Tracking Worksheets” section:

Long-term care facilities reporting COVID-19 vaccination data on residents and healthcare personnel:
LTC Weekly HCP & Resident COVID-19 Vaccination

Inpatient and dialysis facilities reporting COVID-19 vaccination data on healthcare personnel:
Non-LTC Weekly HCP COVID-19 Vaccination

Dialysis facilities reporting COVID-19 vaccination data on patients:
Dialysis Weekly Patient COVID-19 Vaccination

State Supply of Abbott BinaxNOW Tests

Posted on

Missouri has received no new supply from Abbott in the last two weeks and was not notified of a pause from the manufacturer until DHSS inquired this week. All states are experiencing a similar situation, and availability at the state level has been decreasing since the White House announced a federal expansion of at-home testing for Americans. Since then, President Biden announced that hundreds of millions of at-home tests will be made available to Americans in January. With the increase in cases due to high Omicron transmissibility, this issue is being closely monitored as supply and demand changes daily. Missouri is placing a pause on fulfilling re-orders. This pause is due only to the current constrained supply, and we will resume the purchase of antigen tests, once they become available. Our team has identified several options that we are exploring and pursuing now to meet the current testing needs of our existing users as well as the long-term needs.

Effective immediately:

  •         DHSS will not accept new applications from existing test user types. For example, if a facility or organization has not previously received COVID antigen tests – BinaxNOW – through the state warehouse, that facility or organization will not be approved as a new applicant until further notified. We will maintain any new applications received for future potential approval.
  •         Fulfillment of reorders are temporarily being paused until there is clear information regarding the availability of COVID antigen test shipments. DHSS does not know how long this pause may be necessary, but will communicate promptly when the pause is rescinded. This pause was effective with reorders placed 1/3/2022 and subsequently.
  •         During this pause in fulfilment of re-orders, DHSS will prioritize fulfillment of re-orders for any outbreaks. If your facility or organization has a COVID outbreak, please place your reorder and email Kayla.Purnell@health.mo.gov to indicate the outbreak status. To assure prompt processing, please indicate in the e-mail subject line: ‘Outbreak Testing: insert the name of your facility/organization’.

Because the antigen tests are not widely/easily available at this time- you will want to take into consideration creating a testing plan that includes both antigen and PCR testing. The State of Missouri is continuing to reimburse homes for PCR testing related to outbreaks.

 

Reimbursement for OUTBREAK Testing

A reminder that in order to furnish immediate aid and relief in response to the state of emergency due to the spread of COVID-19, the State of Missouri has made some funds from the Coronavirus Relief Fund available to Missouri Long-Term Care facilities with COVID-19 Outbreaks. These funds are available to Long-Term Care facilities that experience an outbreak (one or more positive cases) and are conducting base-line facility testing and some immediate follow-up testing in order to contain outbreaks. For more information: https://apps.dss.mo.gov/LongTermCareCovid19Invoices/.

If you have difficulty obtaining swabs and media from your laboratory- you can order them from Missouri State Public Health Laboratory (MSPH). Your contracted laboratory would still process the samples- not MSPH.

State of Missouri (arcgis.com)

CDC Health Advisory: Using Therapeutics to Prevent and Treat COVID-19

Posted on

Please see the CDC Health Advisory, number 461, dated 12/31/2021, entitled “Using Therapeutics to Prevent and Treat COVID-19.”

Missouri healthcare providers – please contact your Local Public Health Agency or the Missouri Department of Health and Senior Services’ (DHSS’) Bureau of Communicable Disease Control and Prevention at 573-751-6113 or 800-392-0272 (24/7) with questions regarding this CDC Health Advisory.

Governor Parson Announces COVID-19 Related State of Emergency to Expire on December 31

Posted on

Governor Parson Announces COVID-19 Related State of Emergency to Expire on December 31 | Governor Michael L. Parson (mo.gov)

Governor Parson announced on December 30, 2021 the expiration of Executive Order 21-09 (EO 21-09) that declared a State of Emergency related to COVD-19 on December 31, 2021. Since the outset of this public health emergency, the Governor has exercised a legal means by which we have waived certain statutory and regulatory requirements that could have inhibited the state’s response to the public health emergency. However, with the expiration of EO 21-09, the statutory and regulatory waivers also expire.

For long-term care facilities, there are two waivers that had extended timeframes to allow for compliance.  These two waivers are listed below.

  • Individuals working as nurse aides will have 90 days (until April 1st, 2022) to complete the approved nurse aide training program, as required in Section 198.082.1 and 4, RSMo.
  • Regulation 19 CSR 30-84.010(11)(B)4 had been waived to the extent the provisions require a nurse assistant to perform nurse services for monetary compensation for at least one (1) day in a twenty-four (24) consecutive month time period in order to keep his/her certificate valid. The waiver allowed nurse assistants to provide proof of nursing services after the twenty-four (24) month consecutive period has passed. DHSS will tack on the amount of time the COVID-19 response was ongoing plus two (2) months. Nurse assistants must provide proof of performing nursing services by March 1, 2022 to be in good standing.